Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: Implications for white blood cell transfusion therapy

Clinical and Laboratory Haematology

Volumn 19, Issue 1, 1997, Pages 39-47

  Cohen, D M ^a   Bhalla, S C ^b   Anaissie, E J ^b   Hester, J P ^b   Savary, C A ^b   Rex, J H ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NONE   (United States)

Author keywords

G CSF; GM CSF; IFN ; Leucocyte transfusions

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GAMMA RADIATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030895638     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1997.00207.x     Document Type: Article

References (34)

1. Anderson, K.C., Goodnough, L.T., Sayers M. et al. (1991) Variation in blood component irradiation practice: Implications for prevention of transfusion-associated graft-versus-host disease. Blood 10, 2096-2102.
2. Begley C.G., Lopez A.F., Nicola N.A. et al. (1986) Purified colony-stimulated factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 68, 162-166.
3. Bensinger W.I., Price T.H., Dale D.C. et al (1993) The effects of daily recombinant human granulocyte colony-stimulating factor adminstration on normal granulocyte donors undergoing leukapheresis. Blood 81, 1883-1888.
4. Bodey G.P., Buckley M., Sathe Y.S. & Freireich K.J. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals Internal Medicine 64, 328-340.
5. Buescher E.S. & Gallin J.I. (1987) Effects of storage and radiation on human neutrophil function in vitro. Inflammation 11, 401-416.
6. Cebon J., Dempsey P., Fox R, et al. (1988) Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay. Blood 722, 1340-1347.
7. Colotta F., Re F., Polentarutti N., Sozzani S. & Mantovani A. (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020.
8. Deeg H.J., Graham T.C., Gerhard-Miller L., Appelbaum F.R., Schuening F. & Storb R. (1989) Prevention of transfusion-induced grafl-versus-host disease in dogs by ultraviolet irradiation. Blood 74, 2592-2595.
9. Digel W., Zahn G., Heinzel G. & Porzsolt F. (1991) Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients. Cancer Immunology and Immunotherapy 34, 169-174.
10. Fanger M.W., Shen L., Graziano R.G. & Guyre P.M. (1989) Cytotoxicity mediated by human Fc receptors for IgG. Immunology Today 10, 92-99.
11. Fearon D.T. & Collins L.A. (1983) Increased expression of C3b receptors on polymorphonuclear leukocytes by chemotactic factors and by purification procedures. Journal of Immunology 130, 370-375.
12. Feldman E., Hester J.P., Anaissie E, et al. (1992) The use of granulocyte colony-stimulating factor (G-CSF) enhanced granulocyte transfusions from normal donors in patients (PTS) with neutropenia-related fungal infection. Blood 80 (Suppl. 1), 414a.
13. Fleischmann J., Golde D.W., Weisbart R.H. & Gasson J.C. (1986) Granulocyte-macrophage colony-simulating-factor enhances phagocytosis of bacteria by human neutrophils. Blood 68, 708-711.
14. Glasser L., Lane T., McCullough J. & Price T. (1983) Neutrophil concentrates: Function considerations, storage, and quality control. Journal of Clinical Apheresis 1, 179-184.
15. Graw R.G., Herzig G., Perry S. & Henderson E.S. (1972) Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. New England Journal of Medicine 287, 367-371.
16. Higby D.J., Yates J.W., Henderson E.S. & Holland J.F. (1975) Filtration leukopheresis for granulocyte transfusion therapy: clinical and laboratory studies. New England Journal of Medicine 292, 761-766.
17. Hollingshead L.M. & Goa K.L. (1991) Recombinant granulocyte colony-stimulating factor: a review of its pharmacological properties and prospective role in neutropenic conditions. Drugs 42, 300-330.
18. Klebanoff S.J., Ozszowski S., van Voorhis W.C., Ledbetter J.A., Waltersdorph A.M. & Schlechte K.G. (1992) Effects of interferon-gamma on human neutrophils: protection from deterioration on storage. Blood 80, 225-234.
19. Korchak H.M., Roos D., Giedd K.N. et al. (1983) Granulocytes without degradation: neutrophil function in granule-depleted cytoplasts. Proceedings of the National Academy of Science USA 80, 4968-4972.
20. McCullough J., Carter S.J. & Quie P.G. (1974a) Effects of anti-coagulants and storage on granulocyte function in bank blood. Blood 43, 207-217.
21. McCullough J., Weiblen B.J. & Quie P.G. (1974b) Chemotactic activity of human granulocytes preserved in various anti-coagulants. Journal of Laboratory and Clinical Medicine 84, 902-906.
22. McCullough J., Weiblen B.J. & Quie P.G. (1976) In vitro function and post-transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis. Blood 48, 315-326.
23. McCullough J., Weiblen B.J. & Fine D. (1983) Effects of storage of granulocytes and their fate in vivo. Transfusion 23, 20-24.
24. McPhail L.C., Shirley P.S., Clayton C.C. & Snyderman R. (1985) Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor. Journal of Clinical Investigation 75, 1735-1739.
25. Price T.H. & Dale D.C. (1978) Neutrophil transfusion: effect of storage and of collection method on neutrophil blood kinetics. Blood 51, 789-798.
26. Price T.H. & Dale D.C. (1979) Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method. donor corticosteroid treatment, and short-term storage. Blood 54, 977-986.
27. Rex J.H., Bhalla S.C., Cohen D.M., Hester J.P., Vartivarian S.E. & Anaissie E.J. (1995) Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-γ and granulocyte colony-stimulating factor. Transfusion 35, 605-611.
28. Savill J., Dransfield I., Hogg N. & Haslett C. (1990) Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343, 170-173.
29. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M. & Haslett C. (1989) Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. Journal of Clinical Investigation 83, 865-875.
30. Stern A.C. & Jones T.C. (1992) The side-effect profile of GM-CSF. Infection 20 (Suppl. 2), S124-S127.
31. Todd P.A. & Goa K.L. (1992) Interferon gamma-1b: a review of its pharmacology and therapeutic potential in chronic granulomatous disease. Drugs 43, 111-122.
32. Watari K., Asano S., Shirafuji N. et al. (1989) Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73, 117-122.
33. Weisbart R.H., Golde D.W., Clark S.C., Wong G.G. & Gasson J.C. (1985) Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 314, 361-363.
34. Young L.S. (1983) The role of granulocyte transfusions in treating and preventing infection. Cancer Treatment Reports 67, 109-111.